نتایج جستجو برای: childhood acute myeloid leukemia

تعداد نتایج: 833756  

Journal: :iranian journal of pathology 2006
hamid tabrizchi mahnaz yazdanpanah behjat kalantarie khandani esmat mozaffari

myeloid sarcoma of female breast is a rare presentation of acute myeloid leukemia (aml). the tumor mass may precede or occur concurrently with aml, cml, myeloproliferative disorders, and/or myelodysplastic syndromes. histologically, it looks like a large cell lymphoma and can be misdiagnosed. a case referred as a suspected case of large cell lymphoma. initial morphological study with convention...

2015
Rashmi M Nagaraju

Leukemia is the most common malignancy of childhood. Chloromas are rare presentations of underlying leukemic disease. It is important to diagnose these cases early in the course as they respond more favourably to focal irradiation. We present a rare case of chloroma of orbit in a young male patient who presented with severe proptosis and a large mass involving the left orbit. The orbital lesion...

Journal: :Japanese journal of clinical oncology 2010
Youngil Koh Inho Kim Ji-Yeon Bae Eun Young Song Hyun-Kyung Kim Sung-Soo Yoon Dong Soon Lee Sung Sup Park Myoung Hee Park Seonyang Park Byoung Kook Kim

BACKGROUND Differences in the clinical course of secondary acute myeloid leukemia according to the type of the preceding disorders are not defined. We compared the outcomes of therapy-related acute myeloid leukemia, acute myeloid leukemia following myelodysplastic syndrome and acute myeloiod leukemia following myeloproliferative neoplasm. We also intended to find prognostic factors in secondary...

Ansari Sh, Kiumarsi A, Rostami T,

Abnormalities of the thyroid gland are among the most frequent endocrine complications observed in childhood cancer survivors. We report an 11 years old girl who developed central hypothyroidism and ACTH deficiency during the chemotherapy for CNS relapse of acute lymphoblastic leukemia before receiving radiotherapy. Keywords: Thyroid gland, hypothyroidism, chemotherapy, acute lymphoblastic leu...

2012
Eddy Supriyadi Anjo J. P. Veerman Sutaryo Ignatius Purwanto Peter M. vd Ven Jacqueline Cloos

The frequency of acute lymphoblastic leukemia (ALL) patients expressing myeloid antigens on their ALL cells varies between 5 and 36% in several different studies. The clinical relevance of myeloid antigen expression in childhood ALL is controversial. In Indonesian patients, no data were present. Therefore, in Yogyakarta, Indonesia, we analyzed 239 ALL patients who were immunophenotyped includin...

Journal: :international journal of hematology-oncology and stem cell research 0
amir hossein emami hematology-oncology department, imam khomeini hospital, tehran university of medical sciences, tehran ramin shekarriz hematology-oncology department, imam khomeini hospital, tehran university of medical sciences, tehran a meysamie community medicine department, faculty of medical sciences, tehran university of medical sciences, tehran, iran ramazanali sharifian hematology-oncology department, imam khomeini hospital, tehran university of medical sciences, tehran, iran r safaei hematology-oncology department, imam khomeini hospital, tehran university of medical sciences, tehran, iran ghlamreza toogheh hematology-oncology department, imam khomeini hospital, tehran university of medical sciences, tehran, iran

introduction: about half of acute myeloid leukemia (aml) adult patients have no cytogenetic abnormalities as a main determinant of complete remission after treatment, so other markers are needed such as flt3-itd (fms-like tyrosine kinase3-internal tandem duplication) mutations in patients with normal karyotype. the objective of this study was assessing the frequency of flt3-itd mutations and it...

Journal: :Journal of medical case reports 2016
Jesus Vera-Aguilera Osama Mukarram Prathibha Nutalapati Mary Mok Anushi Bulumulle Carlos Vera-Aguilera

BACKGROUND Acute myeloid leukemia is typically a disease of the older population and presents mostly in the fifth decade of life. Myeloid sarcoma is a rare initial presentation of acute myeloid leukemia. Previously it has only been documented in children and younger patients. CASE PRESENTATION We present an unusual case of retro-orbital myeloid sarcoma as an initial presentation of acute myel...

Journal: :acta medica iranica 0
azim mehrvar department of pediatric hematology oncology, mahak s’ pediatric cancer treatment and research center, army university of medical science, tehran, iran. mohammad saeid rahiminejad department of pediatric hematology oncology, children’s medical center, tehran, iran. amir abbas hedayati asl department of pediatric hematology oncology, mahak s’ pediatric cancer treatment and research center, azad university of medical science, qom branch, qom, iran. maryam tashvighi department of pediatric hematology oncology, mahak s’ pediatric cancer treatment and research center, mahak hospital, tehran, iran. mohammad faranoush department of pediatric hematology oncology, mahak s’ pediatric cancer treatment and research center, iran university of medical science, tehran, iran. mardawig alebouyeh department of pediatric hematology oncology, mahak s’ pediatric cancer treatment and research center, azad university of medical science, qom branch, qom, iran.

acute myeloblastic leukemia is one of the important malignancies in children. for better managing the prognosis of this disease, there should be enough information about common features of this malignancy. the aim of this study was to evaluate these common features in children with acute myeloblastic leukemia. a total of 104 eligible children less than 15-year-old have been referred from 2007-2...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran seyyedasadollah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran babak bahar hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran masoud iravani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hamdi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

post-remission treatment in patients with acute myeloid leukemia is still controversial. one potent choice for patients with no donor available is autologous stem cell transplantation. the median follow-up period was 18 months and the median age was 26 years old. in the review of 116 recently diagnosed aml patients (except aml- m3) who underwent autologous stem cell transplantation, 72.4% of pa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید